EverQuote (EVER)
(Delayed Data from NSDQ)
$19.55 USD
+0.94 (5.05%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $19.54 -0.01 (-0.05%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth A Momentum C VGM
EverQuote (EVER) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$22.50 | $25.00 | $16.00 | 20.90% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for EverQuote comes to $22.50. The forecasts range from a low of $16.00 to a high of $25.00. The average price target represents an increase of 20.9% from the last closing price of $18.61.
Analyst Price Targets (6 )
Broker Rating
EverQuote currently has an average brokerage recommendation (ABR) of 1.75 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 1.86 a month ago based on seven recommendations.
Of the eight recommendations deriving the current ABR, four are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 50% and 25% of all recommendations. A month ago, Strong Buy made up 42.86%, while Buy represented 28.57%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 3 | 3 | 4 | 4 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.75 | 1.86 | 1.86 | 1.75 | 1.75 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/19/2024 | B. Riley Securities | Zach Cummins | Strong Buy | Strong Buy |
2/27/2024 | Needham & Company | Mayank Tandon | Moderate Buy | Moderate Buy |
2/25/2024 | Canaccord Genuity | Michael Graham | Strong Buy | Strong Buy |
12/12/2023 | Raymond James | Charles G Peters | Hold | Moderate Buy |
12/5/2023 | Craig-Hallum | Jason Kreyer | Not Available | Strong Buy |
11/7/2023 | William Blair | Ralph E Schackart | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.75 |
ABR (Last week) | 1.86 |
# of Recs in ABR | 8 |
Average Target Price | $22.50 |
LT Growth Rate | NA |
Industry | Insurance - Multi line |
Industry Rank by ABR | 71 of 252 |
Current Quarter EPS Est: | -0.09 |